KALA

Conviction 58HealthcareScan · Thu, Jun 25, 2026

Bearish marubozu

KALA$2.58-14.00%

ResistanceSupportVol 14

Vol MA14 187.22K

Mar 26Apr 14May 1May 19Jun 8Jun 25

KALA BIO, Inc.PHARMACEUTICAL PREPARATIONSwww.kalarx.com ↗

Price2.58

Change-14.00%

Gap-0.33%

Rel volume1.22×

Avg volume156.54K

Avg $ vol454.37K

SMA 202.61

SMA 501.77

SMA 2002.13

Price vs 50+46.14%

Price vs 200+21.25%

MA stackmixed

50/200 cross—

Supertrendup · 2.21

RSI (14)51

MACD hist-0.03

MACD crossbear · 0d

Stoch %K / %D33 / 52

ADX (14)44

+DI / −DI26 / 16

RSI divergence—

MACD divergence—

ATR %+15.47%

ADR %13.95%

52w high19.63

52w low0.0793

From 52w high-86.86%

Above 52w low+3153.47%

New 52w highNo

SqueezeOff

Bollinger width67.62%

%B0.48

Donchian pos32.74%

Donchian high3.71

Donchian low2.03

AVWAP (52w high)0.8488

vs AVWAP high+203.95%

AVWAP (52w low)1.07

vs AVWAP low+140.81%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d1.22×

Avg vol (14d)187.22K

Avg vol (20d)156.54K

Avg $ vol (20d)454.37K

Market cap47.96M

RS 3m (vs SPY)+1300.17%

RS 6m (vs SPY)+374.35%

RS line new highNo

Trend template4/8

Technical rank85.6

1 week-9.31%

1 month+18.89%

3 months+1103.92%

6 months+339.82%

1 year-35.50%

YTD+315.39%

P/E-1.78

P/B4.46

P/S—

P/FCF-1.44

EPS-3.31

Div yield—

ROE-250.72%

ROA-219.03%

Debt/Eq4.39

Current7.91

EV/EBITDA-2.40

Gross margin—

Net margin—

Rev growth—

EPS growth29.94%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value93.39M

Revenue—

Net income-1.62M

Gross profit—

Free cash flow-33.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out18.59M

Employees6

ListedThu, Jul 20, 2017

Free float796.55M

Float %83.4%

Short interest70.71K

Days to cover1.0d

Short volume27.4%

Squeeze score8 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction58 / 100

Pattern quality—

Tech rank85.6 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KALA

All disclosures →

No recent disclosed trades by Congress in KALA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KALA

No recent insider (Form 4) filings in KALA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in KALA · 1 recent

EDGAR →

OFFERS-3/AFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.